ID   NTH_HUMAN               Reviewed;         312 AA.
AC   P78549; Q1MVR1; Q99566; Q99794; Q9BPX2;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 2.
DT   07-JAN-2015, entry version 141.
DE   RecName: Full=Endonuclease III-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03183};
DE            Short=hNTH1;
DE            EC=3.2.2.- {ECO:0000255|HAMAP-Rule:MF_03183};
DE            EC=4.2.99.18 {ECO:0000255|HAMAP-Rule:MF_03183};
DE   AltName: Full=Bifunctional DNA N-glycoslyase/DNA-(apurinic or apyrimidinic site) lyase {ECO:0000255|HAMAP-Rule:MF_03183};
DE            Short=DNA glycoslyase/AP lyase {ECO:0000255|HAMAP-Rule:MF_03183};
DE   Flags: Precursor;
GN   Name=NTHL1 {ECO:0000255|HAMAP-Rule:MF_03183}; Synonyms=NTH1, OCTS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAM11786.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8990169; DOI=10.1073/pnas.94.1.109;
RA   Aspinwall R., Rothwell D.G., Roldan-Arjona T., Anselmino C.,
RA   Ward C.J., Cheadle J.P., Sampson J.R., Lindahl T., Harris P.C.,
RA   Hickson I.D.;
RT   "Cloning and characterization of a functional human homolog of
RT   Escherichia coli endonuclease III.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:109-114(1997).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=9831664; DOI=10.1016/S0378-1119(98)00485-5;
RA   Imai K., Sarker A.H., Akiyama K., Ikeda S., Yao M., Tsutsui K.,
RA   Shohmori T., Seki S.;
RT   "Genomic structure and sequence of a human homologue (NTHL1/NTH1) of
RT   Escherichia coli endonuclease III with those of the adjacent parts of
RT   TSC2 and SLC9A3R2 genes.";
RL   Gene 222:287-295(1998).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAM11786.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS TRP-21 AND LEU-234.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ACTIVE SITE, AND
RP   MUTAGENESIS OF LYS-220.
RC   TISSUE=Bone marrow;
RX   PubMed=9705289; DOI=10.1074/jbc.273.34.21585;
RA   Ikeda S., Biswas T., Roy R., Izumi T., Boldogh I., Kurosky A.,
RA   Sarker A.H., Seki S., Mitra S.;
RT   "Purification and characterization of human NTH1, a homolog of
RT   Escherichia coli endonuclease III. Direct identification of Lys-212 as
RT   the active nucleophilic residue.";
RL   J. Biol. Chem. 273:21585-21593(1998).
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RC   TISSUE=Spleen;
RX   PubMed=9045706; DOI=10.1074/jbc.272.10.6733;
RA   Hilbert T.P., Chaung W., Boorstein R.J., Cunningham R.P., Teebor G.W.;
RT   "Cloning and expression of the cDNA encoding the human homologue of
RT   the DNA repair enzyme, Escherichia coli endonuclease III.";
RL   J. Biol. Chem. 272:6733-6740(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-312 (ISOFORMS 1 AND 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-312, FUNCTION, SUBCELLULAR LOCATION,
RP   AND DEVELOPMENTAL STAGE.
RX   PubMed=10882850; DOI=10.1016/S0921-8777(00)00015-X;
RA   Luna L., Bjoras M., Hoff E., Rognes T., Seeberg E.;
RT   "Cell-cycle regulation, intracellular sorting and induced
RT   overexpression of the human NTH1 DNA glycosylase involved in removal
RT   of formamidopyrimidine residues from DNA.";
RL   Mutat. Res. 460:95-104(2000).
RN   [9]
RP   PROTEIN SEQUENCE OF 31-37; 48-56; 61-78; 107-113; 120-126 AND 221-227,
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12144783; DOI=10.1016/S0022-2836(02)00623-X;
RA   Liu X., Roy R.;
RT   "Truncation of amino-terminal tail stimulates activity of human
RT   endonuclease III (hNTH1).";
RL   J. Mol. Biol. 321:265-276(2002).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9611236; DOI=10.1093/nar/26.12.2917;
RA   Takao M., Aburatani H., Kobayashi K., Yasui A.;
RT   "Mitochondrial targeting of human DNA glycosylases for repair of
RT   oxidative DNA damage.";
RL   Nucleic Acids Res. 26:2917-2922(1998).
RN   [11]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9890904; DOI=10.1021/bi9819071;
RA   Dizdaroglu M., Karahalil B., Senturker S., Buckley T.J.,
RA   Roldan-Arjona T.;
RT   "Excision of products of oxidative DNA base damage by human NTH1
RT   protein.";
RL   Biochemistry 38:243-246(1999).
RN   [12]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11380260; DOI=10.1021/bi0028901;
RA   Eide L., Luna L., Gustad E.C., Henderson P.T., Essigmann J.M.,
RA   Demple B., Seeberg E.;
RT   "Human endonuclease III acts preferentially on DNA damage opposite
RT   guanine residues in DNA.";
RL   Biochemistry 40:6653-6659(2001).
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF LYS-220.
RX   PubMed=11695910; DOI=10.1021/bi011053b;
RA   Liu X., Roy R.;
RT   "Mutation at active site lysine 212 to arginine uncouples the
RT   glycosylase activity from the lyase activity of human endonuclease
RT   III.";
RL   Biochemistry 40:13617-13622(2001).
RN   [14]
RP   CATALYTIC ACTIVITY, INTERACTION WITH YBX1, AND ENZYME REGULATION.
RX   PubMed=11287425; DOI=10.1074/jbc.M101594200;
RA   Marenstein D.R., Ocampo M.T., Chan M.K., Altamirano A., Basu A.K.,
RA   Boorstein R.J., Cunningham R.P., Teebor G.W.;
RT   "Stimulation of human endonuclease III by Y box-binding protein 1
RT   (DNA-binding protein B). Interaction between a base excision repair
RT   enzyme and a transcription factor.";
RL   J. Biol. Chem. 276:21242-21249(2001).
RN   [15]
RP   FUNCTION.
RX   PubMed=11328882; DOI=10.1093/nar/29.9.1975;
RA   Matsumoto Y., Zhang Q.M., Takao M., Yasui A., Yonei S.;
RT   "Escherichia coli Nth and human hNTH1 DNA glycosylases are involved in
RT   removal of 8-oxoguanine from 8-oxoguanine/guanine mispairs in DNA.";
RL   Nucleic Acids Res. 29:1975-1981(2001).
RN   [16] {ECO:0000305}
RP   SUBCELLULAR LOCATION, ALTERNATIVE INITIATION, AND MUTAGENESIS OF
RP   40-ARG--ARG-42; ARG-42 AND ARG-57.
RX   PubMed=12531031; DOI=10.1016/S1568-7864(02)00145-3;
RA   Ikeda S., Kohmoto T., Tabata R., Seki Y.;
RT   "Differential intracellular localization of the human and mouse
RT   endonuclease III homologs and analysis of the sorting signals.";
RL   DNA Repair 1:847-854(2002).
RN   [17]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12140329; DOI=10.1093/nar/gkf460;
RA   Miyabe I., Zhang Q.M., Kino K., Sugiyama H., Takao M., Yasui A.,
RA   Yonei S.;
RT   "Identification of 5-formyluracil DNA glycosylase activity of human
RT   hNTH1 protein.";
RL   Nucleic Acids Res. 30:3443-3448(2002).
RN   [18]
RP   FUNCTION, SUBSTRATES, AND ENZYME REGULATION.
RX   PubMed=12519758; DOI=10.1074/jbc.M212168200;
RA   Marenstein D.R., Chan M.K., Altamirano A., Basu A.K., Boorstein R.J.,
RA   Cunningham R.P., Teebor G.W.;
RT   "Substrate specificity of human endonuclease III (hNTH1). Effect of
RT   human APE1 on hNTH1 activity.";
RL   J. Biol. Chem. 278:9005-9012(2003).
RN   [19]
RP   FUNCTION, AND SUBSTRATES.
RX   PubMed=14734554; DOI=10.1074/jbc.M400393200;
RA   Katafuchi A., Nakano T., Masaoka A., Terato H., Iwai S., Hanaoka F.,
RA   Ide H.;
RT   "Differential specificity of human and Escherichia coli endonuclease
RT   III and VIII homologues for oxidative base lesions.";
RL   J. Biol. Chem. 279:14464-14471(2004).
RN   [20]
RP   FUNCTION, AND SUBSTRATES.
RX   PubMed=15533839; DOI=10.1016/j.dnarep.2004.08.002;
RA   Zhang Q.M., Yonekura S., Takao M., Yasui A., Sugiyama H., Yonei S.;
RT   "DNA glycosylase activities for thymine residues oxidized in the
RT   methyl group are functions of the hNEIL1 and hNTH1 enzymes in human
RT   cells.";
RL   DNA Repair 4:71-79(2005).
RN   [21]
RP   FUNCTION.
RX   PubMed=17923696; DOI=10.1128/MCB.00791-07;
RA   Prasad A., Wallace S.S., Pederson D.S.;
RT   "Initiation of base excision repair of oxidative lesions in
RT   nucleosomes by the human, bifunctional DNA glycosylase NTH1.";
RL   Mol. Cell. Biol. 27:8442-8453(2007).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [23]
RP   FUNCTION.
RX   PubMed=20005182; DOI=10.1016/j.dnarep.2009.11.005;
RA   Odell I.D., Newick K., Heintz N.H., Wallace S.S., Pederson D.S.;
RT   "Non-specific DNA binding interferes with the efficient excision of
RT   oxidative lesions from chromatin by the human DNA glycosylase,
RT   NEIL1.";
RL   DNA Repair 9:134-143(2010).
RN   [24]
RP   FUNCTION.
RX   PubMed=20110254; DOI=10.1093/nar/gkq022;
RA   Matsumoto N., Toga T., Hayashi R., Sugasawa K., Katayanagi K., Ide H.,
RA   Kuraoka I., Iwai S.;
RT   "Fluorescent probes for the analysis of DNA strand scission in base
RT   excision repair.";
RL   Nucleic Acids Res. 38:E101-E101(2010).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   FUNCTION.
RX   PubMed=21930793; DOI=10.1128/MCB.05715-11;
RA   Odell I.D., Barbour J.E., Murphy D.L., Della-Maria J.A., Sweasy J.B.,
RA   Tomkinson A.E., Wallace S.S., Pederson D.S.;
RT   "Nucleosome disruption by DNA ligase III-XRCC1 promotes efficient base
RT   excision repair.";
RL   Mol. Cell. Biol. 31:4623-4632(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71 AND SER-73, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- FUNCTION: Bifunctional DNA N-glycosylase with associated
CC       apurinic/apyrimidinic (AP) lyase function that catalyzes the first
CC       step in base excision repair (BER), the primary repair pathway for
CC       the repair of oxidative DNA damage. The DNA N-glycosylase activity
CC       releases the damaged DNA base from DNA by cleaving the N-
CC       glycosidic bond, leaving an AP site. The AP-lyase activity cleaves
CC       the phosphodiester bond 3' to the AP site by a beta-elimination.
CC       Primarily recognizes and repairs oxidative base damage of
CC       pyrimidines. Has also 8-oxo-7,8-dihydroguanine (8-oxoG) DNA
CC       glycosylase activity. Acts preferentially on DNA damage opposite
CC       guanine residues in DNA. Is able to process lesions in nucleosomes
CC       without requiring or inducing nucleosome disruption.
CC       {ECO:0000269|PubMed:10882850, ECO:0000269|PubMed:11328882,
CC       ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:11695910,
CC       ECO:0000269|PubMed:12140329, ECO:0000269|PubMed:12144783,
CC       ECO:0000269|PubMed:12519758, ECO:0000269|PubMed:14734554,
CC       ECO:0000269|PubMed:15533839, ECO:0000269|PubMed:17923696,
CC       ECO:0000269|PubMed:20005182, ECO:0000269|PubMed:20110254,
CC       ECO:0000269|PubMed:21930793, ECO:0000269|PubMed:8990169,
CC       ECO:0000269|PubMed:9045706, ECO:0000269|PubMed:9705289,
CC       ECO:0000269|PubMed:9890904}.
CC   -!- CATALYTIC ACTIVITY: The C-O-P bond 3' to the apurinic or
CC       apyrimidinic site in DNA is broken by a beta-elimination reaction,
CC       leaving a 3'-terminal unsaturated sugar and a product with a
CC       terminal 5'-phosphate. {ECO:0000250|UniProtKB:P20625,
CC       ECO:0000255|HAMAP-Rule:MF_03183, ECO:0000269|PubMed:11287425,
CC       ECO:0000269|PubMed:12140329, ECO:0000269|PubMed:12144783}.
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC       Note=Binds 1 [4Fe-4S] cluster. The cluster does not appear to play
CC       a role in catalysis, but is probably involved in the proper
CC       positioning of the enzyme along the DNA strand.;
CC   -!- ENZYME REGULATION: APE1 displaces NTHL1 from the N-glycosylase-
CC       generated AP site in DNA, thereby increasing the turnover of the
CC       DNA N-glycosylase activity. AP lyase activity is stimulated by
CC       YBX1. {ECO:0000269|PubMed:11287425, ECO:0000269|PubMed:12519758}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=371 nM for 5-hydroxy-6-hydrothymine containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=1093 nM for 5-hydroxyuracil containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=548 nM for 5-hydroxycytosine containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=1101 nM for thymine glycol containing duplex oligonucleotides
CC         (N-glycosylase activity) {ECO:0000269|PubMed:11380260,
CC         ECO:0000269|PubMed:9890904};
CC         KM=718 nM for 5,6-dihydroxycytosine containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=0.05 nM for 5-hydroxycytosine-G containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=0.2 nM for 5-hydroxycytosine-A containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC   -!- SUBUNIT: Interacts with YBX1. {ECO:0000255|HAMAP-Rule:MF_03183,
CC       ECO:0000269|PubMed:11287425}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=3;
CC       Name=1; Synonyms=M-8;
CC         IsoId=P78549-1; Sequence=Displayed;
CC       Name=2; Synonyms=M+1;
CC         IsoId=P78549-2; Sequence=VSP_054293;
CC       Name=3; Synonyms=M+8;
CC         IsoId=P78549-3; Sequence=VSP_054292;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in heart
CC       and lowest levels in lung and liver. {ECO:0000269|PubMed:8990169,
CC       ECO:0000269|PubMed:9831664}.
CC   -!- DEVELOPMENTAL STAGE: Expression levels are regulated during the
CC       cell cycle with increased levels during early and mid S-phase.
CC       {ECO:0000269|PubMed:10882850}.
CC   -!- SIMILARITY: Belongs to the Nth/MutY family. {ECO:0000255|HAMAP-
CC       Rule:MF_03183}.
CC   -!- SIMILARITY: Contains 1 HhH domain. {ECO:0000255|HAMAP-
CC       Rule:MF_03183}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nthl1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U79718; AAB41534.1; -; mRNA.
DR   EMBL; AB014460; BAA32695.1; -; Genomic_DNA.
DR   EMBL; AF498098; AAM11786.1; -; Genomic_DNA.
DR   EMBL; AC005600; AAC34209.1; -; Genomic_DNA.
DR   EMBL; AB001575; BAA19413.1; -; mRNA.
DR   EMBL; U81285; AAC51136.1; -; mRNA.
DR   EMBL; BC003014; AAH03014.1; -; mRNA.
DR   EMBL; BC000391; AAH00391.2; -; mRNA.
DR   EMBL; Y09687; CAA70865.1; -; mRNA.
DR   CCDS; CCDS10457.1; -. [P78549-1]
DR   RefSeq; NP_002519.1; NM_002528.5. [P78549-1]
DR   UniGene; Hs.66196; -.
DR   ProteinModelPortal; P78549; -.
DR   SMR; P78549; 130-306.
DR   BioGrid; 110968; 14.
DR   STRING; 9606.ENSP00000219066; -.
DR   PhosphoSite; P78549; -.
DR   DMDM; 29840795; -.
DR   MaxQB; P78549; -.
DR   PaxDb; P78549; -.
DR   PRIDE; P78549; -.
DR   GeneID; 4913; -.
DR   KEGG; hsa:4913; -.
DR   UCSC; uc002col.1; human. [P78549-1]
DR   CTD; 4913; -.
DR   GeneCards; GC16M002089; -.
DR   HGNC; HGNC:8028; NTHL1.
DR   HPA; CAB025152; -.
DR   MIM; 602656; gene.
DR   neXtProt; NX_P78549; -.
DR   PharmGKB; PA31811; -.
DR   eggNOG; COG0177; -.
DR   GeneTree; ENSGT00510000047513; -.
DR   HOGENOM; HOG000252209; -.
DR   HOVERGEN; HBG052675; -.
DR   InParanoid; P78549; -.
DR   KO; K10773; -.
DR   OMA; WRNKVKY; -.
DR   OrthoDB; EOG76MK8Z; -.
DR   PhylomeDB; P78549; -.
DR   TreeFam; TF314967; -.
DR   BRENDA; 4.2.99.18; 2681.
DR   Reactome; REACT_1064; Displacement of DNA glycosylase by APE1.
DR   Reactome; REACT_702; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   GeneWiki; NTHL1; -.
DR   GenomeRNAi; 4913; -.
DR   NextBio; 18903; -.
DR   PRO; PR:P78549; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Bgee; P78549; -.
DR   CleanEx; HS_NTHL1; -.
DR   ExpressionAtlas; P78549; baseline and differential.
DR   Genevestigator; P78549; -.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0019104; F:DNA N-glycosylase activity; IDA:UniProtKB.
DR   GO; GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0004519; F:endonuclease activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006284; P:base-excision repair; TAS:Reactome.
DR   GO; GO:0006285; P:base-excision repair, AP site formation; IDA:UniProtKB.
DR   GO; GO:0045008; P:depyrimidination; TAS:Reactome.
DR   GO; GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC.
DR   GO; GO:0006281; P:DNA repair; TAS:Reactome.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; IDA:UniProtKB.
DR   Gene3D; 1.10.1670.10; -; 1.
DR   Gene3D; 1.10.340.30; -; 1.
DR   HAMAP; MF_03183; Endonuclease_III_Nth; 1.
DR   InterPro; IPR011257; DNA_glycosylase.
DR   InterPro; IPR004036; Endonuclease-III-like_CS2.
DR   InterPro; IPR003651; Endouclease3_FeS-loop_motif.
DR   InterPro; IPR003265; HhH-GPD_domain.
DR   InterPro; IPR000445; HhH_motif.
DR   InterPro; IPR023170; HTH_base_excis_C.
DR   Pfam; PF00633; HHH; 1.
DR   Pfam; PF00730; HhH-GPD; 1.
DR   SMART; SM00478; ENDO3c; 1.
DR   SMART; SM00525; FES; 1.
DR   SUPFAM; SSF48150; SSF48150; 1.
DR   PROSITE; PS01155; ENDONUCLEASE_III_2; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Alternative initiation; Complete proteome;
KW   Direct protein sequencing; DNA damage; DNA repair; Glycosidase;
KW   Hydrolase; Iron; Iron-sulfur; Lyase; Metal-binding; Mitochondrion;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     30       Mitochondrion. {ECO:0000255|HAMAP-
FT                                Rule:MF_03183,
FT                                ECO:0000269|PubMed:12144783}.
FT   CHAIN        31    312       Endonuclease III-like protein 1.
FT                                /FTId=PRO_0000102227.
FT   DOMAIN      199    223       HhH. {ECO:0000255|HAMAP-Rule:MF_03183}.
FT   MOTIF        36     60       Bipartite nuclear localization signal.
FT                                {ECO:0000255}.
FT   ACT_SITE    220    220       Nucleophile; for N-glycosylase activity.
FT                                {ECO:0000255|HAMAP-Rule:MF_03183,
FT                                ECO:0000269|PubMed:9705289}.
FT   METAL       290    290       Iron-sulfur (4Fe-4S). {ECO:0000255|HAMAP-
FT                                Rule:MF_03183}.
FT   METAL       297    297       Iron-sulfur (4Fe-4S). {ECO:0000255|HAMAP-
FT                                Rule:MF_03183}.
FT   METAL       300    300       Iron-sulfur (4Fe-4S). {ECO:0000255|HAMAP-
FT                                Rule:MF_03183}.
FT   METAL       306    306       Iron-sulfur (4Fe-4S). {ECO:0000255|HAMAP-
FT                                Rule:MF_03183}.
FT   SITE        239    239       Important for catalytic activity.
FT   MOD_RES      71     71       Phosphoserine.
FT                                {ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES      73     73       Phosphoserine.
FT                                {ECO:0000269|PubMed:21406692}.
FT   VAR_SEQ       1     15       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054292.
FT   VAR_SEQ       1      8       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9045706,
FT                                ECO:0000303|PubMed:9705289,
FT                                ECO:0000303|PubMed:9831664}.
FT                                /FTId=VSP_054293.
FT   VARIANT      21     21       R -> W (in dbSNP:rs3087469).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_016125.
FT   VARIANT      33     33       R -> K (in dbSNP:rs2302172).
FT                                /FTId=VAR_016126.
FT   VARIANT     176    176       I -> T (in dbSNP:rs1805378).
FT                                /FTId=VAR_016127.
FT   VARIANT     234    234       S -> L (in dbSNP:rs3211977).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_029318.
FT   VARIANT     239    239       D -> Y (in dbSNP:rs3087468).
FT                                /FTId=VAR_016128.
FT   MUTAGEN      40     42       Missing: Sorted to the cytoplasm.
FT                                {ECO:0000269|PubMed:12531031}.
FT   MUTAGEN      42     42       R->A: Sorted to both nuclei and
FT                                mitochondria.
FT                                {ECO:0000269|PubMed:12531031}.
FT   MUTAGEN      42     42       R->D: Sorted to the cytoplasm.
FT                                {ECO:0000269|PubMed:12531031}.
FT   MUTAGEN      57     57       R->A,D: Sorted to both nuclei and
FT                                mitochondria.
FT                                {ECO:0000269|PubMed:12531031}.
FT   MUTAGEN     220    220       K->Q: Inactivates enzyme.
FT                                {ECO:0000269|PubMed:11695910,
FT                                ECO:0000269|PubMed:9705289}.
FT   MUTAGEN     220    220       K->R: 85-fold reduction in activity.
FT                                Uncouples the glycosylase activity from
FT                                the lyase activity. Shows glycosylase
FT                                activity without any detectable AP-lyase
FT                                activity during the first 10 min of the
FT                                reaction. {ECO:0000269|PubMed:11695910,
FT                                ECO:0000269|PubMed:9705289}.
FT   CONFLICT      9     10       MT -> TS (in Ref. 8; CAA70865).
FT                                {ECO:0000305}.
FT   CONFLICT     78     78       Missing (in Ref. 8; CAA70865).
FT                                {ECO:0000305}.
FT   CONFLICT    151    151       M -> I (in Ref. 1; AAB41534).
FT                                {ECO:0000305}.
FT   CONFLICT    160    160       T -> A (in Ref. 1; AAB41534).
FT                                {ECO:0000305}.
SQ   SEQUENCE   312 AA;  34390 MW;  379816A1E0B45050 CRC64;
     MCSPQESGMT ALSARMLTRS RSLGPGAGPR GCREEPGPLR RREAAAEARK SHSPVKRPRK
     AQRLRVAYEG SDSEKGEGAE PLKVPVWEPQ DWQQQLVNIR AMRNKKDAPV DHLGTEHCYD
     SSAPPKVRRY QVLLSLMLSS QTKDQVTAGA MQRLRARGLT VDSILQTDDA TLGKLIYPVG
     FWRSKVKYIK QTSAILQQHY GGDIPASVAE LVALPGVGPK MAHLAMAVAW GTVSGIAVDT
     HVHRIANRLR WTKKATKSPE ETRAALEEWL PRELWHEING LLVGFGQQTC LPVHPRCHAC
     LNQALCPAAQ GL
//
